Bruce Merlin Fried and Henry J. Aaron speak at Dec. 9 audioconference, Health Reform Under President Obama: Likely Priorities and Time Frames for 8 Possible Initiatives


AIS Compliance Health Reform Pharmacy Benefit Consumer-Directed Care Compliance Market Data Health Plans
 HOME
 New on the Site
Customer Service
Sample Newsletters MarketPlace
AIS Products & Services

E-Savings Club weekly specials

Free E-Mail Newsletters
Health Business Daily
Government News
Sign Up for Free E-Mail Newsletters

Health Business Job Openings

Health Business Meetings

People on the Move
 
Health Plans
General Business Issues
Product News
Company Intelligence
Disease Management
Blue Cross and Blue Shield
Medicare Advantage
Managed Medicaid
Health Plan Products
 
Compliance
Compliance Strategies
HIPAA Resource Center
Government Resources
Compliance Products
 
Pharmacy Benefit
Pharmacy Benefit Mgmt.
Specialty Pharmacy
Drug Mgmt. Products
 
Consumer-Directed Care
Articles on CDH
CDH Data
CDH Products
 
Market Data
Health Plan Enrollment
Pharmacy Benefit Mgmt.
Data Products
 
Health Reform
Obama Administration
Federal Legislation
State Legislation
State Results
Association Positions
Research Organizations
 
MarketPlace
Newsletters
Web Services & Looseleaf Guides
Books & Reports, Directories & Databases
Live Meetings & Audioconferences
Alphabetical Listing
 

Health Care Links
 

 
Visit AISEducation.com for more news and strategic information for today's business leaders
 

Articles on Compliance Strategies

OIG Drops Rule on Exclusion When Medicare Charges Exceed Those of Private Payers

Reprinted from the June 25, 2007, issue of REPORT ON MEDICARE COMPLIANCE, the nation's leading source of news and strategic information on false claims, overpayments, compliance programs, billing errors and other Medicare compliance issues.

Almost four years after OIG proposed a rule fleshing out its authority to exclude providers for charging Medicare or Medicaid 120% or more than they charge other payers for the same items or services, OIG withdrew the rule June 18. One big reason: OIG concluded there's not enough data to set a uniform fixed benchmark that could be applied equitably across the industry.

The withdrawal notice was published in the Federal Register. The withdrawal means that "OIG has listened to what representatives from the industry told them - the 120% proposal didn't make sense across the board," says Los Angeles attorney Tim Blanchard, who notes that OIG reviewed 323 comments.

Even though the regulation is gone, the law at the root of it is still in effect, and OIG said it will enforce the law on a case-by-case basis (though it apparently has never been enforced). The law is a section of the Social Security Act that authorizes OIG to use its permissive-exclusion authority against individuals and entities that bill Medicare substantially in excess of what the usual charges are for other payers.

"OIG will continue to evaluate billing patterns for individuals and entities on a case-by-case basis and will use all tools available to address instances where Medicare or Medicaid are charged substantially more than others without good cause," OIG spokesman Don White tells RMC. "This is the situation as it has been for a long time. We tried with [the proposed rule] to clarify it."

Notwithstanding the withdrawal, OIG wants to make it absolutely clear that hospitals can still discount bills to uninsured and underinsured patients without skewing charges. "Providers can still do that," says Washington, D.C., attorney Anne Sullivan, who is with the law firm Morgan, Lewis & Bockius. "The withdrawal of this proposed rule doesn't change OIG's interpretation.that the calculation of usual charges need not include the free or reduced charges to the uninsured and underinsured, without dropping your other prices." OIG says as much in a June 18 addendum to its 2004 guidance on hospital discounts (see story below).

A lot of angst has surrounded this regulation, which had its roots in the Medicare and Medicaid Patient and Program Protection Act of 1987. Congress gave OIG the authority to exclude providers for substantially excessive charges, but neither Congress nor OIG ever spelled out exactly what that meant. In 2003, OIG came up with a bright-line definition of "substantially in excess": when providers charge Medicare 120% more than they charge other payers for the same goods and services. The rule applies to various services subject to Medicare fee schedules, including outpatient drugs, medical supplies and clinical lab work, but it explicitly exempts the physician fee schedule because it is based on very trustworthy data, OIG says. The proposed rule exempted charges to uninsured or underinsured patients from the calculations.

Ultimately, OIG felt it couldn't enforce a bright-line standard like 120%. In the withdrawal notice, OIG said it was concerned it lacked enough data to "to establish a single, fixed numerical benchmark for 'substantially in excess' that could be applied equitably across health care sectors and across items and services." OIG also isn't sure the rule wouldn't end up raising health care costs. But the Medicare watchdog agency's worries persist about discrepancies between amounts that providers and suppliers charge Medicare and Medicaid versus what they charge private payers.

Blanchard, who is with the law firm of McDermott, Will & Emery in Los Angeles, says it became clear that "it might not be good for the public or the programs if the rule were vigorously enforced because of likely unintended consequences affecting some providers that are part of the safety net."

 

High-Risk Areas in Medicare Billing - Compliance Auditing Tools for Hospitals and Health Systems

receive free reports

HIPAA & Medicare Compliance Resources


Advertise With AIS

Privacy

Site Map



Copyright © 2008 by Atlantic Information Services, Inc. All rights reserved.
1100 17th Street, NW, Suite 300, Washington, DC 20036
Phone 202-775-9008 or 800-521-4323; E-mail
customerserv@aispub.com